DRRX Share Price

Open 0.97 Change Price %
High 0.98 1 Day 0.01 1.03
Low 0.97 1 Week -0.03 -2.97
Close 0.98 1 Month -0.24 -19.67
Volume 153516 1 Year -0.15 -13.27
52 Week High 2.00
52 Week Low 0.96
DRRX Important Levels
Resistance 2 0.99
Resistance 1 0.99
Pivot 0.98
Support 1 0.97
Support 2 0.97
NASDAQ USA Most Active Stocks
DRYS 2.24 -4.68%
FNFG 10.18 -0.20%
DELL 13.86 0.22%
RFMD 16.59 -2.07%
RIMM 13.03 0.39%
BBEP 0.12 0.00%
GTAT 0.44 0.00%
SUSQ 14.20 -0.77%
ACAS 17.99 0.39%
ASTI 0.00 0.00%
More..
NASDAQ USA Top Gainers Stocks
MYRX 0.10 100.00%
LOCM 0.09 50.00%
CEMP 4.05 28.57%
WRES 0.09 28.57%
BSDM 0.62 26.53%
SNTA 0.34 25.93%
OTT 2.39 25.13%
SKBI 0.10 25.00%
IPCI 2.55 18.60%
QKLS 0.15 15.38%
More..
NASDAQ USA Top Losers Stocks
TXCC 0.01 -95.00%
HCIIP 10.10 -67.52%
GMETP 0.70 -59.54%
CRMB 0.27 -57.81%
KIOR 0.03 -57.14%
EDMC 0.01 -50.00%
QTWW 0.08 -50.00%
SPIR 0.01 -50.00%
OSH 0.26 -49.02%
OSH 0.26 -49.02%
More..

Durect Corporation (NASDAQ: DRRX)

DRRX Technical Analysis 5
As on 24th Feb 2017 DRRX Share Price closed @ 0.98 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 1.36 & Strong Sell for SHORT-TERM with Stoploss of 1.18 we also expect STOCK to react on Following IMPORTANT LEVELS.
DRRX Target for February
1st Target up-side 1.26
2nd Target up-side 1.39
3rd Target up-side 1.53
1st Target down-side 0.86
2nd Target down-side 0.73
3rd Target down-side 0.59
DRRX Other Details
Segment EQ
Market Capital 87659144.00
Sector Healthcare
Industry Drug Manufacturers - Other
Offical website http://www.durect.com
DRRX Address
DRRX
10260 Bubb Road
Cupertino, CA 95014
United States
Phone: 408-777-1417
Fax: 408-777-3577
DRRX Latest News
DURECT Corporation (DRRX) Settles Into New 52-Week Low on February 16 Session   Equities.com   - 17th Feb 17
DURECT Corporation Risk Points versus Health Care   CML News   - 14th Feb 17
DURECT Corporation (DRRX) Settles Into New 52-Week Low on February 08 Session   Equities.com   - 09th Feb 17
DURECT Corporation Announces Update on DUR-928 Development Program   Yahoo Finance   - 30th Jan 17
Durect Corporation Seeking More Collaborations   Seeking Alpha   - 15th Nov 16
DURECT Corporation Announces Third Quarter 2016 Financial Results and Update ...   PR Newswire (press release)   - 01st Nov 16
Here's Why DURECT Corporation Is Tanking Today   Motley Fool   - 26th Sep 16
How To Trade Durect Heading Into Remoxy Decision Date   Seeking Alpha   - 02nd Aug 16
A Comprehensive Update On DURECT Corp.   Seeking Alpha   - 01st May 15
Durect Corp. DRRX (US: Nasdaq)   Wall Street Journal   - 11th Feb 11
Interactive Technical Analysis Chart Durect Corporation ( DRRX NASDAQ USA )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Durect Corporation
DRRX Business Profile
Durect Corporation is a specialty pharmaceutical company focused on the development of pharmaceutical products based on its drug delivery technology platforms. The Company�s product pipeline, as of December 31, 2012, consisted of eight investigational drug candidates in clinical development, with one program the subject of a New Drug Application (NDA) with the United States Food and Drug Administration (FDA), with one program in Phase III with an NDA in preparation, two programs in Phase II and three programs in Phase I. The Company�s products candidates include Remoxy, POSIDUR, ELADUR, TRANSDUR-Sufentanil, Relday, ORADUR-based opioid, ORADUR-ADHD, Relday and other products. The Company's developments are focused on the application of its drug delivery technologies to potential products in a variety of chronic and episodic disease areas, including pain, central nervous system (CNS) disorders, cardiovascular disease and other chronic diseases.